RecruitingNCT05246813

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study


Sponsor

Imelda Hospital, Bonheiden

Enrollment

24 participants

Start Date

Feb 11, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.


Eligibility

Min Age: 55 Years

Inclusion Criteria1

  • Age 65 years and older

Exclusion Criteria2

  • known haematological condition (myelodysplasia, leukemia, cancer)
  • inability to provide written informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood and bone marrow cell collection

Collection of blood and bone marrow


Locations(1)

Imelda Hospital

Bonheiden, België, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05246813


Related Trials